(Q48853497)

16 February 2018

title

Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients (English)

1 reference

16 February 2018

0 references

1 reference

Murphy DL

1

1 reference

16 February 2018

Brodie HK

series ordinal

2

1 reference

16 February 2018

Goodwin FK

series ordinal

3

1 reference

16 February 2018

Bunney WE Jr

series ordinal

4

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 January 1971

1 reference

16 February 2018

number of pages

2

1 reference

inferred from page(s)

published in

Nature

1 reference

16 February 2018

volume

229

1 reference

16 February 2018

issue

5280

1 reference

16 February 2018

page(s)

135-136

1 reference

16 February 2018

Modification of Parkinsonism--chronic treatment with L-dopa

cites work

1 reference

Treatment of Parkinsonism With Levodopa

21 January 2018

1 reference

Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

21 January 2018

1 reference

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

Norepinephrine in depressive reactions. A review

21 January 2018

1 reference

Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.

21 January 2018

1 reference

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

7 January 2021

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

1 reference

7 January 2021

[On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]

1 reference

7 January 2021

CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION

1 reference

7 January 2021

The effects of dopa on inhibited depressions

1 reference

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

7 January 2021

L-dopa in postencephalitic parkinsonism.

1 reference

7 January 2021

L-dopa in idiopathic parkinsonism.

1 reference

7 January 2021

Effects of L-dopa in Parkinson's disease.

1 reference

7 January 2021

Effect of L-DOPA on depression

1 reference

7 January 2021

L-dopa in depressed patients.

1 reference

7 January 2021

Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients

1 reference

7 January 2021

Biogenic Amines and Emotion

1 reference

7 January 2021

The switch process from depression to mania: relationship to drugs which alter brain amines

1 reference

7 January 2021

Methods for reliable longitudinal observation of behavior

1 reference

7 January 2021

Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II

1 reference

7 January 2021

Hyperactive states related to the metabolism of norepinephrine and similar biochemicals.

1 reference

7 January 2021

L-dopa and cerebrospinal fluid homovanillic acid in parkinsonism

1 reference

7 January 2021

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

1 reference

7 January 2021

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/229135A0

1 reference

16 February 2018

Dimensions Publication ID

1020611129

0 references

1 reference

16 February 2018